Methods and apparatus are described that use an array of two or more cold plasma jet ports oriented to converge at a treatment area. The use of an array permits greater tissue penetration by cold plasma treatments. This approach enables treatment of deeper infections of soft and hard tissues without surgical intervention. For example, this approach can treat sub-integumental infections, such as those common to joint replacements, without surgically opening the issues overlying the deeper infection.

Patent
   9472382
Priority
Dec 31 2012
Filed
Dec 31 2013
Issued
Oct 18 2016
Expiry
Sep 18 2034
Extension
261 days
Assg.orig
Entity
Small
26
79
currently ok
1. An apparatus comprising:
an annular structure having two or more cold plasma devices positioned to provide converging cold plasma jets that converge at a treatment area, wherein at least one of the two or more cold plasma devices is coupled to one or more high voltage RF power supplies.
13. A method comprising:
receiving, from a cold plasma power supply, electrical energy at two or more cold plasma devices, wherein the two or more cold plasma devices are located on an annular structure, and wherein the cold plasma power supply is a harmonic high voltage RF power supply;
receiving, from a gas source, gas at the two or more cold plasma devices; and
outputting cold plasma from the two or more cold plasma devices to converge at a treatment area.
2. The apparatus of claim 1, wherein the two or more cold plasma devices are positioned in a circumferential orientation.
3. The apparatus of claim 1, wherein the annular structure is configured to expand in a first direction.
4. The apparatus of claim 1, wherein the annular structure is configured to expand in a first direction and in a second direction.
5. The apparatus of claim 4, wherein the first direction and the second direction are orthogonal directions.
6. The apparatus of claim 1, wherein the two or more cold plasma devices are configured to generate two or more cold plasma jets that are diametrically opposed to one another, the treatment area being located between the two or more cold plasma devices.
7. The apparatus of claim 1, wherein the two or more cold plasma devices are coupled to a common triggering mechanism to simultaneously activate the two or more cold plasma devices.
8. The apparatus of claim 1, wherein functionality settings of the two or more cold plasma devices are independently configurable to provide a desired treatment regime at the treatment area.
9. The apparatus of claim 8, wherein the functionality settings of the two or more cold plasma devices include functionality settings by using computer control.
10. The apparatus of claim 1, wherein at least one of the two or more cold plasma devices is a multi-frequency harmonic-rich cold plasma device.
11. The apparatus of claim 1, wherein at least one of the two or more cold plasma devices is free of internal ground electrodes.
12. The apparatus of claim 1, wherein the annular structure is configured to surround the treatment area.
14. The method of claim 13, wherein the two or more cold plasma devices are located in a circumferential orientation.
15. The method of claim 13, wherein the annular structure is configured to expand in a first direction.
16. The method of claim 13, wherein the annular structure is configured to expand in a first direction and in a second direction.
17. The apparatus of claim 16, wherein the first direction and the second direction are orthogonal directions.
18. The method of claim 13, wherein outputting cold plasma from the two or more cold plasma devices includes outputting cold plasma in jets that are diametrically opposed to one another, the treatment area being located between the two or more cold plasma devices.
19. The method of claim 13, wherein the two or more cold plasma devices are coupled to a common triggering mechanism to simultaneously activate the two or more cold plasma devices.
20. The method of claim 13, wherein functionality settings of the two or more cold plasma devices are independently configurable to provide a desired treatment regime.
21. The method of claim 20, wherein the functionality settings of the two or more cold plasma devices include functionality settings by using computer control.
22. The method of claim 13, wherein at least one of the two or more cold plasma devices is a multi-frequency harmonic-rich cold plasma device, and outputting cold plasma includes outputting multi-frequency harmonic-rich cold plasma.
23. The method of claim 13, wherein receiving electrical energy at two or more cold plasma devices includes receiving electrical energy at at least one of the two or more cold plasma devices, wherein the at least one of the two or more cold plasma devices is free of internal ground electrodes.
24. The method of claim 13, wherein the annular structure is configured to surround the treatment area.

This application claims the benefit of U.S. Provisional Application No. 61/747,428, filed Dec. 31, 2012 and entitled “Cold Plasma Toroidal Array Methods and Apparatus,” which is incorporated herein by reference in its entirety.

This application is related to U.S. Provisional Application No. 60/913,369, filed Apr. 23, 2007; U.S. patent application Ser. No. 12/038,159, filed Feb. 27, 2008 (which issued as U.S. Pat. No. 7,633,231); U.S. patent application Ser. No. 13/620,118, filed Sep. 14, 2012; and U.S. patent application Ser. No. 14/026,679, filed Sep. 13, 2013, each of which are herein incorporated by reference in their entireties.

1. Field of the Art

The present invention relates to devices and methods for cold plasma application, and, more particularly, to arrays of such devices that are formed in an annular shape and methods for using same.

2. Background Art

When infections of deep tissues occur in the body it is often necessary to perform a surgical procedure to expose the infection, manually clean or debride the site, pack it with antibiotics, and initiate systemic antibiotics in an attempt to resolve the infection. In the case of orthopedic infections, where there is hardware of metallic or plastic composition present, the standard course of treatment may require multiple surgical procedures. Since the hardware may be covered in bacterial colonies and there is limited vascularization of the tissues immediately contacting the hardware, the colonization of the hardware often can't be controlled with systemic antibiotic use alone. In the case of an infected total joint replacement, the surgeon will often perform a “two-stage revision” procedure. The first stage involves opening the joint, removing the hardware, debriding infected tissue, packing the region with antibiotic impregnated materials, and closing the incision. Along with systemic antibiotics, the antibiotic materials are left in the patient, often with a non-functional joint complex, for on average 6 weeks. After blood and joint fluid tests suggest resolution of the infection, a second procedure is performed to remove the antibiotic laden materials and implant a new functional joint replacement. In some cases the infection is still present locally even though blood indicators are normal, and the new implant may quickly become re-infected, starting the “2-stage revision” procedure over again. In extreme cases, amputation may be the prescribed course of action for severe extremity infections that fail to resolve after these measures.

It is therefore highly desirable to be able to eradicate a deep joint infection without the need for repeated surgeries and a reliance on antibiotics to reach the site either through the circulatory system or by local, internal, long-term application. The same applies to other bone and deep tissue infections, abscesses, and similar conditions familiar to those in the medical field. As cold plasmas also show promise in the treatment of malignant growths, this array would have use in the treatment of deep tissue tumors, or any disorder that requires greater depth of penetration of plasma, including musculoskeletal pain and inflammation.

An embodiment is described of an apparatus having an annular structure with two or more cold plasma devices located on the annular structure and directed internal to the annular structure so as to converge at a treatment area. The two or more cold plasma devices are coupled to one or more high voltage RF ports and to one or more gas supply ports.

A further embodiment is described of a method of producing cold plasma for use in a medical treatment. The method includes receiving, from a cold plasma power supply, electrical energy at two or more cold plasma devices via one or more high voltage RF ports. The two or more cold plasma devices are located on an annular structure. The method also includes receiving, from a gas source, gas at the two or more cold plasma devices via one or more gas supply ports. Finally, the method includes outputting cold plasma from the two or more cold plasma devices, the cold plasma from these cold plasma devices being directed to converge at a treatment area.

FIG. 1 illustrates an embodiment of the cold plasma annular treatment device that includes an array of a plurality of plasma ports.

FIG. 2 illustrates an embodiment that provides an adjustable four-port array of a plurality of cold plasma ports in an annular orientation.

FIG. 3 illustrates an embodiment of a four-port, adjustable array (in a closed position) of a plurality of cold plasma ports in an annular orientation.

FIG. 4 illustrates an embodiment where two cold plasma ports are positioned to be diametrically opposed to one another, with convergence of the resulting cold plasma jets occurring between the two cold plasma ports.

FIG. 5 illustrates a flowchart of a method for providing two or more cold plasma jets that converge at a treatment area, according to an embodiment of the present disclosure.

Cold temperature plasmas have attracted a great deal of enthusiasm and interest by virtue of their provision of plasmas at relatively low gas temperatures. The provision of plasmas at such a temperature is of interest to a variety of applications, including wound healing, anti-bacterial processes, tumor treatments, anti-inflammatory treatments, non-infective disorders that may be treatable with cold plasmas, and various other medical therapies and sterilization.

Conventional cold plasma treatments were focused on treatment areas at the surface of the skin, as it was not previously known that cold plasmas could penetrate the surface of the skin. Consequently, no contemplation was previously considered as to approaches by which cold plasma penetration for treatment purposes could be improved or optimized. However, recent data that is described in U.S. patent application Ser. No. 14/026,679, entitled “Therapeutic Applications of Cold Plasma,” filed Sep. 13, 2013, indicate that subcutaneous treatment protocols are feasible with cold plasmas. In particular, paragraphs [0084]-[0089] of this referenced application provide data in support of the proposition that cold plasma penetrates beneath the skin so that internal tissue treatments are feasible.

Consideration of the penetration effects of cold plasma indicates that the penetration can be thought of as a cone of attenuation below the skin surface. The cold plasma intensity decreases due to the spreading effect associated with the conical penetration shape below the skin surface. It is therefore desirable to be able to increase the penetration and/or to increase the intensity at various depths below the surface of the skin. By generating multiple “cones” of treatment in the tissues, with some degree of overlap, the desirable effects in deep tissues can be amplified. Therefore, increasing the intensity at various targeted depths below the skin surface, the volumetric problem of certain internal tissues disorders can be addressed.

Embodiments of the present disclosure include an annular device designed with an array of two or more individual cold plasma (CP) jet ports oriented to converge about a patient's body segment (either at the skin surface or below the skin surface) resulting in a plurality of treatment angles (FIG. 1). The effective penetration of a typical cold plasma jet is generally on the order of <2 cm. By arranging a plurality of jets circumferentially around the desired treatment zone, penetration to deeper tissues is possible and more complete. Embodiments of the cold plasma annular treatment device can be used to treat sub-integumental infections, such as abscess, bone, and joint infections, without surgically opening the tissues overlying the deeper infection. The ability to treat deep infections of the soft and hard tissues of the body without surgical intervention greatly reduces the risk of secondary complications (comorbidities), reduces pain, and decreases the cost of treating these infections. Other beneficial applications of cold plasma, such as treating tumors or musculoskeletal disorders would also benefit from improved penetration.

The device, designed similarly to a modern magnetic resonance imaging (MRI) machine, allows the patient's injured or infected segment to be placed inside of the machine, which is designed in an annular shape to surround the affected area, FIG. 2 illustrates an adjustable symmetrical array of cold plasma ports surround the segment to apply a treatment of the desired duration and intensity. The array could consist of any number of ports (FIG. 1, for example, illustrates 4 ports, but two or more ports are contemplated to be within the scope of the present disclosure) to expand the degree of coverage of treatment through an overlapping and/or converging plurality of plasma jets. The annular array could be molded in unique sections, such as four sections (FIG. 2) and assembled after manufacture. The ports themselves can be designed and manufactured to each provide a cold plasma jet, using any approach known to one skilled in the art. As an example (which is not intended to be limiting), the cold plasma jet sources may be the multi-frequency harmonic-rich cold plasma (MFHCP) devices described in U.S. Provisional Patent Application No. 60/913,369, U.S. Non-provisional application Ser. No. 12/038,159 (that has issued as U.S. Pat. No. 7,633,231) and the subsequent continuation applications (collectively “the '369 application family”), which are incorporated herein by reference. Included in the description in U.S. Pat. No. 7,633,231 are devices that form cold plasma without the use of internal ground electrodes. Furthermore, the high voltage RF power supply may be (but not limited to) that described in the '369 patent family, or in U.S. patent application Ser. No. 13/620,118, filed Sep. 14, 2012, which is also incorporated herein by reference. In both the cold plasma device and high voltage RF power supply, the scope of this invention is not limited to these particular examples, but covers all cold plasma devices and high voltage RF power supplies.

On the cold plasma annular treatment device, the devices would be activated remotely by a common trigger mechanism to generate plasma. This common trigger mechanism could be a physical flow control or a computer console that triggers a plurality of valves and RF energy. The devices would be affixed to the annular array, as illustrated for example in FIG. 1.

FIG. 1 illustrates an embodiment of the cold plasma annular treatment device that includes a symmetrical array of a plurality of plasma ports. In this embodiment, four (4) ports 120a, 120b, 120c, 120d are illustrated, although two or more ports falls within the scope of various embodiments of the present invention. Attached to each port is a cold plasma generation unit 110a, 110b, 110c, 110d with the plasma flow directed as shown to converge at an interior region. Each cold plasma generation unit 110 is connected by a high-voltage RF feed cable 160 to one or more high voltage RF power supplies 150, and a gas supply line 130 to a suitable supply of gas 140. The cold plasma annular treatment structure can be modified to fit the appropriate size permitted by the each of the plasma ports, as well as the intended treatment area. A sliding/locking mechanism 170 is illustrated that allows the cold plasma annular treatment structure to expand or contract as necessary to make the appropriate physical accommodation. The high voltage RF power supplies can be similar to those described in the '369 application family.

FIG. 2 illustrates an embodiment that provides an adjustable four-port array of a plurality of cold plasma ports 220 in an annular orientation. Since the distance between the plasma outlet port and treatment target are critical for effective treatment and tissue penetration, the internal treatment area of the array can be adjusted to optimize the distance between the plasma outlet ports and the target area (e.g., a patient's body segment) undergoing treatment. Sliding/locking mechanism 170 may be in an open position 210, or in a closed position 230. Sliding/locking mechanism 170 makes use of an adjustment track 240. The array can be expanded or contracted as needed, and locked into place to ensure consistent and optimized treatment distances. As can be readily surmised by an examination of the Figures, the array can be adjusted in one direction, or in a second direction. The second direction can be orthogonal, or at another suitable angle, to the first direction. Such adjustment directions are merely exemplary, and serve to illustrate the flexibility of adjustment envisaged for various embodiments within the scope of the present invention.

FIG. 3 illustrates an embodiment of a four-port, adjustable symmetrical array (in a closed position using sliding/locking mechanism 310) of a plurality of cold plasma ports in an annular orientation. Although FIG. 3 illustrates the possibility of four ports, only two ports 320a, 320b are occupied for this particular treatment regime. As expected, cold plasma 330a, 330b emanates and converges to a treatment area (not shown). In this embodiment, the two cold plasma sources are on the same side of the treatment area.

In the context of this application, an annular cold plasma structure includes the scenario where two cold plasma ports are aligned diametrically opposed to one another, with a treatment area located in between the two cold plasma ports to receive cold plasma from those two cold plasma ports. FIG. 4 illustrates such an embodiment, with cold plasma devices 430a, 430b positioned to be diametrically opposed to one another. Each cold plasma device 430 receives a source of electrical energy via high voltage RF feed line 420 and gas via gas feed line 410. Cold plasma 440a, 440b emanates from cold plasma devices 430a, 430b to reach treatment area (not shown) that is in between cold plasma devices 430a, 430b.

FIG. 5 provides a flowchart of a method for providing two or more cold plasma jets that converge at a treatment area, according to an embodiment of the present disclosure.

The process begins at step 510. In step 510, electrical energy is received at two or more cold plasma devices, wherein the cold plasma devices are located on an annular structure.

In step 520, gas is received at the two or more cold plasma devices.

In step 530, cold plasma is output from the two or more cold plasma devices so as to converge at a treatment area.

At step 540, method 500 ends.

Although the above description has used the '369 application family as the baseline cold plasma device, the scope of the present invention is not limited to the '369 application family baseline. The '369 application family baseline is merely exemplary and not limiting, and therefore embodiments of the present invention include the deployment of the above annular features to cold plasma generation devices in general, irrespective of their means of generation.

As noted above, the four-port configuration is exemplary, and not a limiting of various embodiments of the present invention. Other numbers of ports fall within the scope of various embodiments of the present invention. Further, although a symmetric configuration is described above, non-symmetric or asymmetric configurations of ports can also be used to provide a particular treatment protocol, and such non-symmetric/asymmetric configurations also fall within the scope of various embodiments of the present invention.

It is to be appreciated that the Detailed Description section, and not the Summary and Abstract sections, is intended to be used to interpret the claims. The Summary and Abstract sections may set forth one or more but not all exemplary embodiments of the present invention as contemplated by the inventor(s), and thus, are not intended to limit the present invention and the appended claims in any way.

The present invention has been described above with the aid of functional building blocks illustrating the implementation of specified functions and relationships thereof. The boundaries of these functional building blocks have been arbitrarily defined herein for the convenience of the description. Alternate boundaries can be defined so long as the specified functions and relationships thereof are appropriately performed.

The foregoing description of the specific embodiments will so fully reveal the general nature of the invention that others can, by applying knowledge within the skill of the art, readily modify and/or adapt for various applications such specific embodiments, without undue experimentation, without departing from the general concept of the present invention. Therefore, such adaptations and modifications are intended to be within the meaning and range of equivalents of the disclosed embodiments, based on the teaching and guidance presented herein. It is to be understood that the phraseology or terminology herein is for the purpose of description and not of limitation, such that the terminology or phraseology of the present specification is to be interpreted by the skilled artisan in light of the teachings and guidance.

The breadth and scope of the present invention should not be limited by any of the above-described exemplary embodiments, but should be defined only in accordance with the following claims and their equivalents.

Jacofsky, Marc C.

Patent Priority Assignee Title
10213246, Nov 13 2009 Hermes Innovations LLC Tissue ablation systems and method
10674594, Apr 23 2007 Plasmology4, Inc. Harmonic cold plasma device and associated methods
10675087, Apr 29 2015 Cirrus Technologies Ltd Medical ablation device and method of use
10692704, Nov 10 2016 GOJO Industries, Inc Methods and systems for generating plasma activated liquid
10716611, May 15 2015 CLEAR INTRADERMAL TECHNOLOGIES, INC Systems and methods for tattoo removal using cold plasma
10765850, May 12 2016 GOJO Industries, Inc Methods and systems for trans-tissue substance delivery using plasmaporation
11019716, Apr 23 2007 PLASMOLOGY4, INC Harmonic cold plasma device and associated methods
11253311, Apr 22 2016 Relign Corporation Arthroscopic devices and methods
11259787, Oct 15 2013 Hermes Innovations LLC Laparoscopic device
11439453, May 15 2015 CLEAR INTRADERMAL TECHNOLOGIES, INC Systems and methods for tattoo removal using cold plasma
11490947, May 15 2015 CLEAR INTRADERMAL TECHNOLOGIES, INC Tattoo removal using a liquid-gas mixture with plasma gas bubbles
11554214, Jun 26 2019 MEDITRINA, INC Fluid management system
11576718, Jan 20 2016 Relign Corporation Arthroscopic devices and methods
11629860, Jul 17 2018 TRANSIENT PLASMA SYSTEMS, INC. Method and system for treating emissions using a transient pulsed plasma
11659647, Apr 23 2007 Plasmology4, Inc. Harmonic cold plasma device and associated methods
11696388, May 07 2019 TRANSIENT PLASMA SYSTEMS, INC. Pulsed non-thermal atmospheric pressure plasma processing system
11724078, May 12 2016 GOJO Industries, Inc. Methods and systems for trans-tissue substance delivery using plasmaporation
11735399, Nov 10 2016 GOJO Industries, Inc. Methods and systems for generating plasma activated liquid
11766291, Jul 01 2016 Relign Corporation Arthroscopic devices and methods
11793563, Apr 22 2016 Relign Corporation Arthroscopic devices and methods
11896282, Nov 13 2009 Hermes Innovations LLC Tissue ablation systems and method
11911086, Oct 21 2008 Hermes Innovations LLC Endometrial ablation devices and systems
11911090, Dec 19 2018 CLEAR INTRADERMAL TECHNOLOGIES, INC Systems and methods for tattoo removal using an applied electric field
12064160, May 15 2015 Clear Intradermal Technologies, Inc. Tattoo removal using a liquid-gas mixture with plasma gas bubbles
12070263, Oct 21 2008 Hermes Innovations LLC Endometrial ablation method
9646808, Dec 31 2012 Plasmology4, Inc. Cold plasma annular array methods and apparatus
Patent Priority Assignee Title
2927322,
3432722,
3487414,
3735591,
4088926, May 10 1976 Plasma cleaning device
4365622, Sep 11 1980 Donald L. Morton & Associates Multiple plate resonant electrode
4380320, Feb 25 1981 Nordson Corporation Electrostatic powder spray gun nozzle
4422013, Jul 21 1981 The United States of America as represented by the Secretary of the Navy MPD Intense beam pulser
5079482, Feb 25 1991 Directed electric discharge generator
5216330, Jan 14 1992 UNIVERSITY OF ROCHESTOR Ion beam gun
5225740, Mar 26 1992 General Atomics Method and apparatus for producing high density plasma using whistler mode excitation
5304888, Jan 24 1992 Applied Materials, Inc Mechanically stable field emission gun
5698164, Dec 27 1994 OHNIT CO , LTD Low-temperature plasma generator
5876663, Nov 12 1996 The University of Tennessee Research Corporation Sterilization of liquids using plasma glow discharge
5883470, Feb 16 1996 Ebara Corporation Fast atomic beam source with an inductively coupled plasma generator
5909086, Sep 24 1996 Bovie Medical Corporation Plasma generator for generating unipolar plasma
5961772, Jan 23 1997 Los Alamos National Security, LLC Atmospheric-pressure plasma jet
5977715, Dec 14 1995 The Boeing Company; Boeing Company, the Handheld atmospheric pressure glow discharge plasma source
6096564, May 25 1999 Wisconsin Alumni Research Foundation Plasma-aided treatment of surfaces against bacterial attachment and biofilm deposition
6099523, Jun 27 1995 Bovie Medical Corporation Cold plasma coagulator
6113851, Mar 01 1996 STERILUCENT, INC Apparatus and process for dry sterilization of medical and dental devices and materials
6204605, Mar 24 1999 The University of Tennessee Research Corporation Electrodeless discharge at atmospheric pressure
6225593, Feb 15 1997 Helica Instruments Limited Medical apparatus for generating an ionised gas plasma flame
6228330, Jun 08 1999 Triad National Security, LLC Atmospheric-pressure plasma decontamination/sterilization chamber
6262523, Apr 21 1999 Triad National Security, LLC Large area atmospheric-pressure plasma jet
6278241, Nov 13 1995 Tepla AG Four-nozzle plasma generator for forming an activated jet
6441554, Nov 28 2000 SE PLASMA INC Apparatus for generating low temperature plasma at atmospheric pressure
6455014, May 14 1999 FLIR DETECTION, INC Decontamination of fluids or objects contaminated with chemical or biological agents using a distributed plasma reactor
6611106, Mar 19 2001 FLORIDA RESEARCH FOUNDATION, UNIVERSITY OF Controlled fusion in a field reversed configuration and direct energy conversion
6667007, Jan 12 2000 TRUSTEES OF PRINCETON UNIVERSITY, THE System and method of applying energetic ions for sterilization
6956329, Aug 04 2000 General Atomics Apparatus and method for forming a high pressure plasma discharge column
6958063, Apr 22 1999 ACIST MEDICAL SYSTEMS, INC Plasma generator for radio frequency surgery
7006874, Jan 05 1996 THERMAGE, INC Treatment apparatus with electromagnetic energy delivery device and non-volatile memory
7011790, May 07 2001 Regents of the University of Minnesota Non-thermal disinfection of biological fluids using non-thermal plasma
7037468, May 14 1999 FLIR DETECTION, INC Decontamination of fluids or objects contaminated with chemical or biological agents using a distributed plasma reactor
7081711, Oct 28 2003 EXCELITAS TECHNOLOGIES CORP Inductively generated streaming plasma ion source
7094314, Jun 16 2003 Ionfield Holdings, LLC Atmospheric pressure non-thermal plasma device to clean and sterilize the surfaces of probes, cannulas, pin tools, pipettes and spray heads
7192553, Dec 15 1999 STEVENS INSTITUTE OF TECHNOLOGY; Plasmasol Corporation In situ sterilization and decontamination system using a non-thermal plasma discharge
7215697, Aug 27 1999 Matched impedance controlled avalanche driver
7271363, Sep 01 2004 RECARBON, INC Portable microwave plasma systems including a supply line for gas and microwaves
7300436, Feb 22 2000 ENERGIST LIMITED Tissue resurfacing
7608839, Aug 05 2005 McGill University Plasma source and applications thereof
7633231, Apr 23 2007 PLASMOLOGY4,INC Harmonic cold plasma device and associated methods
7683342, Sep 16 2005 MAX-PLANCK GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E V ; Adtec Europe Limited Plasma source
7691101, Jan 06 2006 Arthrocare Corporation Electrosurgical method and system for treating foot ulcer
7719200, Mar 07 2005 OLD DOMINION UNIVERSITY RESEARCH FOUNDATION Plasma generator
7777151, Feb 14 2008 Adventix Technologies Inc. Portable plasma sterilizer
7785322, Feb 22 2000 ENERGIST LIMITED Tissue treatment system
7799290, May 14 1999 FLIR DETECTION, INC Decontamination of fluids or objects contaminated with chemical or biological agents using a distributed plasma reactor
8267884, Oct 07 2005 Surfx Technologies LLC Wound treatment apparatus and method
8294369, May 04 2009 OLD DOMINION UNIVERSITY RESEARCH FOUNDATION Low temperature plasma generator having an elongate discharge tube
8460283, Apr 03 2009 OLD DOMINION UNIVERSITY RESEARCH FOUNDATION Low temperature plasma generator
20020129902,
20030222586,
20050088101,
20050179395,
20060189976,
20080159925,
20090188626,
20100133979,
20110022043,
20120100524,
20120187841,
20120259270,
20130022514,
20130053762,
20130134878,
20130199540,
20140000810,
WO2005084569,
WO2006116252,
WO2007124910,
WO2010107722,
WO2011055368,
WO2011055369,
WO2011076193,
WO2012106735,
WO2012153332,
WO2013101673,
///
Executed onAssignorAssigneeConveyanceFrameReelDoc
Dec 31 2013Plasmology4, Inc.(assignment on the face of the patent)
Jan 07 2014JACOFSKY, MARC C COLD PLASMA MEDICAL TECHNOLOGIES, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0320170674 pdf
Dec 18 2014COLD PLASMA MEDICAL TECHNOLOGIES, INC PLASMOLOGY4, INC CHANGE OF NAME SEE DOCUMENT FOR DETAILS 0389450295 pdf
Date Maintenance Fee Events
Mar 09 2017ASPN: Payor Number Assigned.
Apr 06 2020M2551: Payment of Maintenance Fee, 4th Yr, Small Entity.
Apr 17 2024M2552: Payment of Maintenance Fee, 8th Yr, Small Entity.


Date Maintenance Schedule
Oct 18 20194 years fee payment window open
Apr 18 20206 months grace period start (w surcharge)
Oct 18 2020patent expiry (for year 4)
Oct 18 20222 years to revive unintentionally abandoned end. (for year 4)
Oct 18 20238 years fee payment window open
Apr 18 20246 months grace period start (w surcharge)
Oct 18 2024patent expiry (for year 8)
Oct 18 20262 years to revive unintentionally abandoned end. (for year 8)
Oct 18 202712 years fee payment window open
Apr 18 20286 months grace period start (w surcharge)
Oct 18 2028patent expiry (for year 12)
Oct 18 20302 years to revive unintentionally abandoned end. (for year 12)